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Imidazoleglycerol-phosphate dehydratase (IGPD)
catalyzes the Mn(II)-dependent dehydration of imi-
dazoleglycerol phosphate (IGP) to 3-(1H-imidazol-
4-yl)-2-oxopropyl dihydrogen phosphate during
biosynthesis of histidine. As part of a program of her-
bicide design, we have determined a series of high-
resolution crystal structures of an inactive mutant
of IGPD2 from Arabidopsis thaliana in complex with
IGP. The structures represent snapshots of the
enzyme trapped at different stages of the catalytic
cycle and show how substrate binding triggers a
switch in the coordination state of an active site
Mn(II) between six- and five-coordinate species.
This switch is critical to prime the active site for catal-
ysis, by facilitating the formation of a high-energy
imidazolate intermediate. This work not only pro-
vides evidence for the molecular processes that
dominate catalysis in IGPD, but also describes how
the manipulation of metal coordination can be linked
to discrete steps in catalysis, demonstrating oneway
that metalloenzymes exploit the unique properties of
metal ions to diversify their chemistry.
INTRODUCTION
Metalloenzymes account for more than half of known enzymes
(Foster et al., 2014) and are fundamental in facilitating many of
the core metabolic processes that are essential for life. The
chemical diversity and functionality of metalloenzymes is depen-
dent upon their ability to utilize the unique chemistry ofmetal ions
to facilitate specific reactions (Finkelstein, 2009; Frausto da Silva
and Williams, 2001; Karlin, 1993). Numerous biophysical,
biochemical, and structural studies have provided insights into
how metal ions promote catalysis, highlighting their involvement
in bond polarization and stabilization of transition states and in-
termediates (Andreini et al., 2008). Moreover, in the case of1236 Structure 23, 1236–1245, July 7, 2015 ª2015 Elsevier Ltd All rigcertain redox enzymes, for example manganese superoxide dis-
mutase (Abreu and Cabelli, 2010) and oxalate decarboxylase
(Tabares et al., 2009), changes in the oxidation state of the metal
ions have been associated with variations in ligand coordination
geometry during the reaction (Andreini et al., 2008). However,
there is still much to be learned about the exact roles that
different metal ions play in driving enzyme catalysis, specifically
how the exquisite specificity with which they are selected is
matched to the chemistry in which they are involved.
The metalloenzyme imidazoleglycerol-phosphate dehydra-
tase (IGPD) (EC 4.2.1.19) has been identified as a potential her-
bicide target due to its essential role in histidine biosynthesis
(Ames, 1957; Hilton et al., 1965). It catalyzes the Mn(II)-depen-
dent dehydration of (2R,3S)-2,3-dihydroxy-3-(1H-imidazol-5-yl)
propyl dihydrogen phosphate (2R3S IGP) to 3-(1H-imidazol-4-
yl)-2-oxopropyl dihydrogen phosphate (IAP). A previous struc-
ture of IGPD isoform 1 from Arabidopsis thaliana (IGPD1) (PDB:
2F1D) (Glynn et al., 2005) and a second from Mycobacterium
tuberculosis (PDB: 4GQU) (Ahangar et al., 2013) has shown
that IGPD is a homo 24mer with two manganese ions, 6.5 A˚
apart, bound at each of the catalytic centers. These structures,
and other biochemical data, have revealed that, unlike other en-
zymes, where Mn2+ can be exchanged with Mg2+ or Zn2+ with
little effect on activity (Andreini et al., 2008), IGPD has both a
structural andmechanistic requirement formanganese (Petersen
et al., 1997). Analysis of the IGPD1 structure, coupled with the
observation that triazole-phosphonate compounds are potent in-
hibitors of theenzyme (Hawkeset al., 1993; Jin et al., 2015; Lindell
et al., 1996; Mori et al., 1995), has suggested that the reaction
(Figure 1A) proceeds via an initial high-energy deprotonation of
the substrate imidazole ring (pKa14.5) to yield an anionic imida-
zolate (Walba and Isensee, 1961), which is then converted to the
product via diazafulvene and enol intermediates. Since the sub-
strate lacks a carbonyl or imine adjacent to the leaving proton,
which is thus non-acidic, IGPD uses an unusual mechanism for
catalysis that is distinct from other dehydration reactions that
have been reported to date (Glynn et al., 2005).
As part of a program of herbicide development designed to
combat increasing resistance to glyphosate, we sought to
expand our understanding of the enzyme mechanism by study-
ing the structure of the IGPD in complex with its substrate, IGP,hts reserved
Figure 1. IGPD Catalyzes the Mn(II)-Depen-
dent Dehydration of IGP to IAP
(A) Schematic drawing representing an overview of
the reaction mechanism of IGPD, highlighting the
key intermediates. Figure generated using Chem-
Draw.
(B) Structure-based sequence alignment showing
equivalent residues in A. thaliana IGPD2 (ARA-
THA2) and IGPD1 (ARATHA1). Black and gray
shading indicates identical or similar residues,
respectively. Secondary structure elements are
numbered and represented as gray arrows (beta
strands), tubes (helices), and lines (loop regions)
above the sequence. The C loop is labeled and
shown as a gray line. Black dots indicate residues
that are involved in metal ion binding. Residues
implicated in recognition of the substrate-phos-
phate are marked with a black triangle. Numbering
is based on the convention adopted in the structure
of IGPD1 (PDB: 2F1D) (Glynn et al., 2005).
Sequences were retrieved from UniProt, the align-
ment was produced using Tcoffee, and the figure
was drawn using boxshade. See also Figure S1.and also with inhibitors. In this paper, we describe two distinct
crystal structures of the enzyme-substrate complex, one that
represents initial capture of the substrate by the enzyme and
a second in which the substrate is bound as the activated
high-energy imidazolate form that is primed for catalysis. Anal-
ysis of the interconversion between the two forms reveals that
progression through the catalytic cycle is a highly dynamic pro-
cess involving conformational changes to both the substrate
and the protein. Central to this process is the repeated switch
in coordination state of an active site Mn(II) between six- and
five-coordinate species. These different coordination states
are linked to specific steps in the reaction and serve to control
progression through the catalytic cycle. This study therefore
explains how an enzyme can exploit a feature of transition
metals to augment the functionality of proteins, providing in-
sights into one of the roles that divalent metal ions can play
in catalysis.
RESULTS
The Form A Enzyme-Substrate Complex Contains
a Ligand-Depleted Five-Coordinate Mn(II) Ion
To provide a foundation on which to analyze substrate binding,
we determined the structure of A. thaliana IGPD isoform 2
(IGPD2) in complex with inorganic phosphate (1.75 A˚ resolution)
(Table 1), which is a weak inhibitor of the enzyme (Ki 5 mM)
(Wiater et al., 1971a). The native protein crystallized as the
same 24mer species that has been observed previously (Fig-
ure S2), and this structure shows that within the active site ofStructure 23, 1236–1245, July 7, 2015the holoenzyme, both of the Mn(II) ions
are octahedrally coordinated by four
conserved protein ligands (Figures 1B
and S1) and two water molecules;
HOH3/HOH4 for Mn1 and HOH1/HOH2,
for Mn2 (Figure 2A). The structure also
shows that a phosphate ion binds in asite surrounded by a number of conserved positively charged
residues (Q51, H55, R99, and K177) (Figure 2B), which are equiv-
alent to those that surround the site of a bound sulfate ion in the
IGPD1 complex (PDB: 2F1D) (Glynn et al., 2005). The holoen-
zyme has an open conformation where the C-terminal region
(R193–R206, termed the C loop), which contains a number of
conserved residues, is disordered (Figures 1B and S1).
To study substrate binding in IGPD, we used site-directed
mutagenesis to produce an inactive mutant of A. thaliana
IGPD2 by replacing E21, a putative acid-base catalyst, with a
glutamine residue. The E21Q IGPD2 mutant was confirmed to
be inactive using a modified version of the stopped assay previ-
ously described by Ames (1957) and Hawkes et al. (1995), which
showed no signal above background. E21Q IGPD2 was co-crys-
tallized with substrate to yield a 1.12 A˚ resolution structure of the
enzyme-substrate complex, termed form A (Table 1). The elec-
tron density clearly showed that the crystal contained a mixture
of the enzyme bound to either the substrate, 2R3S IGP, or the
2S3S diastereoisomer, which is a by-product of the synthesis
and is not a substrate of the enzyme (Hawkes et al., 1995; Saika
et al., 1993) (Figure S3). Both diastereoisomers bind at the same
site, with the enzyme adopting the same, open conformation
equivalent to that of the holoenzyme, including the disordered
C loop. The mode of binding of the substrate in the form A com-
plex is comparable to that seen in the 2.1 A˚ resolutionMycobac-
terium tuberculosis IGPD-substrate complex (Ahangar et al.,
2013), but the substantially increased resolution of the structure
described here has enabled a much deeper analysis of how
IGPD interacts with its substrate.ª2015 Elsevier Ltd All rights reserved 1237
Table 1. Data Collection and Refinement Statistics
IGPD2+Pi
(PDB: 4QNK)
IGPD2+1,2,4-Triazole
(PDB: 4MU0)
E21Q IGPD2 Form A + IGP
(PDB: 4MU3)
E21Q IGPD2 Form B + IGP
(PDB: 4MU4)
Data Collection
Beamline Diamond I02 Diamond I24 Diamond I02 Diamond I24
Wavelength (A˚) 0.9507 0.9686 0.9794 0.9686
Space group and unit cell
parameters (A˚) a = b = c =
I23 P432 P432 P432
225.13 113.1 113.1 112.9
Molecules per asymmetric unit 8 1 1 1
Resolution (A˚) 71.19–1.75 (1.84–1.75) 50.59–1.3 (1.33–1.3) 46.17–1.12 (1.14–1.12) 65.18–1.41 (1.45–1.41)
Unique observations 187811 (27,248) 61,097 (4421) 94,992 (6558) 47,547 (3450)
Rmerge
a 0.118 (0.579) 0.053 (0.762) 0.041 (0.568) 0.085 (0.849)
Rpim
b 0.062 (0.325) 0.023 (0.324) 0.016 (0.303) 0.029 (0.282)
Mean((I)/SD(I)) 11.7 (2.2) 25.2 (3.5) 30.8 (2.5) 17.7 (3.4)
Completeness (%) 99.4 (99.4) 100.0 (99.9) 99.1 (93.9) 100.0 (100.0)
Multiplicity 4.2 (4.0) 12.3 (12.5) 9.5 (4.7) 10.5 (10.8)
Refinement
No. of non-H atoms 13,061 1654 1753 1818
R factor/Rfree
c (%) 13.3 (22.0)/18.9 (30.1) 13.0 (23.2)/14.8 (25.2) 12.2 (23.1)/13.8 (23.0) 12.4 (18.60)/15.4 (23.1)
Average B factors (A˚2) 20 15 15 16
Bond length rmsd (A˚) 0.013 0.011 0.012 0.012
Bond angle rmsd () 1.5 1.5 1.8 1.5
Ramachandran values 1431/1481 favored 187/193 favored 187/194 favored 203/209 favored
50 allowed 6 allowed 6 allowed 6 allowed
Values in parentheses are data in the highest-resolution shell. Rmsd, root-mean-square deviation.
aRmerge = Shkl Si j Ii – Imj/Shkl Si Ii.
bRpim = Shkl O1/n  1Si=1 j Ii  Imj/Shkl Si Ii, where Ii and Im are the observed intensity and mean intensity of related reflections, respectively.
cR factor = (SjjFoj  jFcjj/SjFoj) 3 100, where Fo and Fc are observed and calculated structure factor amplitudes. Rfree is calculated using 5% of
reflections omitted from refinement.In the form A complex, the 2R3S substrate forms a bidentate
interaction with Mn1 via the imidazole-N1 nitrogen atom and
the C3-OH group, which replace HOH3 and HOH4 as ligands
to the metal ion, respectively (Figures 3A and 3B). Mn1 therefore
retains the octahedral coordination seen in the holoenzyme
complex. In contrast to Mn1, the second manganese ion, Mn2,
is five-coordinate, sharing the same four protein ligands (E77,
H145, H73, and H170) and one water ligand (HOH1) with those
seen in the holoenzyme structure. However, the position of the
imidazole-N3 nitrogen atom of the substrate is such that it would
be too close to that of HOH2, the sixth Mn2 ligand in the holoen-
zyme. This potential steric clash in the form A complex is avoided
by the prior displacement of HOH2 from the enzyme (Figure 3B).
The substrate imidazole-N3 nitrogen atom forms a hydrogen
bond to HOH1, which in turn is hydrogen bonded to two
conserved carboxyl groups (E77 and D108). This arrangement
implies that the imidazole ring is neutral, with its N3 nitrogen
atom protonated and acting as a hydrogen bond donor, consis-
tent with its high pKa (14.5) for deprotonation. Compared with
the holoenzyme structure, the position of Mn2 is shifted 0.5 A˚
out of the plane of the four metal ligands HOH1, O-E77,
N-H73, and N-H170 (Figures 3B and 3C). This movement is
also accompanied by a shortening of the mean metal-ligand dis-
tances by approximately 0.1 A˚ compared with other octahedrally
coordinated Mn(II) ions in complexes of IGPD (Table 2). The1238 Structure 23, 1236–1245, July 7, 2015 ª2015 Elsevier Ltd All rigstructure of form A therefore shows that IGPD links the binding
of its substrate to the generation of a ligand-depleted, five-coor-
dinate Mn(II) ion at the heart of the active site.
The Form B Enzyme-Substrate Complex Traps the
Imidazolate Form of IGP
A second set of crystallization conditions yielded crystals in the
same space group and with equivalent cell dimensions to those
observed in form A. However, in the structure determined from
these crystals (1.41 A˚ resolution) (Table 1), termed form B, both
the enzyme and the substrate have strikingly different conforma-
tions to those seen in form A. In this structure, the C loop is or-
dered and buries the substrate from solvent, forming a closed
conformation of the enzyme, which has not been reported previ-
ously (Figure 3D). The position of the C loop in form B occludes
the site where an ethylene glycol molecule, originating from the
crystallization precipitant, is located in form A. Unlike the situa-
tion in form A, where the active site is occupied by a mixture of
two diastereoisomers of IGP, in formB the electron density could
be explained by the binding of a single molecule of the 2R3S IGP
substrate, with only a small number of disconnected, very low-
level difference features seen around the substrate binding site
(Figure S4). The conformational changes observed in the C
loop cause the side chain of S199 to occlude the phosphate
binding site observed in form A, resulting in the phosphate grouphts reserved
Figure 2. Mn Coordination and Ligand Binding in the Complexes of
IGPD2 with Phosphate and 1,2,4-Triazole
(A) In the holoenzyme structure, two manganese ions (Mn1 and Mn2) are
octahedrally coordinated each by three histidine residues, a glutamate
(from chains A and A0) and two water molecules (labeled HOH1-4). The
1.75-A˚ 2mFo-DFc electron density map (gray mesh) is shown surrounding
the metal ions and their ligands, contoured at 1.2 s. The protein backbone
and side-chain carbon atoms are shown in yellow (chain A) or gold (chain
A0), with other atoms in atom colors (N blue, O red, and P orange). The
metal ions and selected water molecules are labeled and shown as purple
or red spheres, respectively. Metal ion interactions are shown as black
dashes.
(B) Each active site of the 24mer is constructed at the interface between three
chains, labeled A, A0, and C. The phosphate binding site is surrounded by a
cluster of highly conserved basic residues (Gln51A, His55A, Lys177A, and
Arg99C) that are hydrogen bonded (orange dashes) to the phosphate ion. The
relative position of the manganese ions and the two putative catalytic residues
(Glu21A andGlu173A) are also shown, with labels for themetal ligands omitted
Structure 23, 1of the IGP being repositioned in a new site, approximately 2.2 A˚
away from that seen in form A (Figure 4). This forces the sub-
strate to adopt a radically different mode of binding, such that
the IGP-phosphate group in form B makes new interactions
with R121, S199, and K201, while maintaining those with R99
and K177, albeit with minor conformational changes to these
side chains. Moreover, the shift in phosphate position is accom-
panied by major changes in the torsion angles of the substrate.
While these changes do not affect the position of the imid-
azole-N1 atom within the coordination sphere of Mn1, they do
result in the exchange of the C3-OH for the C2-OH as the second
ligand to Mn1 (Figures 3D and 3E). This generates a different
geometric arrangement around the metal ion and is accompa-
nied by a shift in the position of the IGP-imidazole, which in
form B sits equidistant between the two metal ions. Thus, the
imidazole-N1 and -N3 nitrogen atoms interact directly with
Mn1 and Mn2, respectively, with both of the metal ions octahe-
drally coordinated and lying in the plane of the imidazole ring
(Figure 3F). This implies that both nitrogen atoms in the imidazole
ring are deprotonated and that the ring is bound as an imidazo-
late anion, providing the first direct evidence for the existence of
the imidazolate as an intermediate in the reaction. Furthermore,
the conformation of the substrate is such that the C2, C3, and the
imidazolate ring of the IGP lie in approximately the same plane,
closely resembling the sp2 geometry of the carbon backbone
in the proposed diazafulvene intermediate. The structure of
form B therefore shows that when IGPD is in complex with the
imidazolate intermediate, its active site is in a closed conforma-
tion and is solvent inaccessible, with both metal ions octahe-
drally coordinated.
As the C loop forms a crucial part of the active site in the formB
complex, and since the conserved residues in this region form
part of the phosphate binding site (Figure 4), we investigated
whether the C loop was required for activity. A C-terminal dele-
tion mutant (residues 170–176) was made in the IGPD homolog
from Pyrococcus furiosus (Pf). Activity tests on the wild-type pro-
tein, using a modified version of a stopped assay protocol at
65C (Ames, 1957; Hawkes et al., 1995) gave a specific activity
of50 mmol IAPmg1min1. In contrast, no activity above back-
ground could be recorded for the DC-loop IGPD, demonstrating
that the C loop is essential for catalysis.
1,2,4-Triazole Mimics the Binding of the Imidazolate
IGPD is inhibited by 1,2,4-triazole and 3-amino-1,2,4-triazole
(amitrole) (Hilton et al., 1965; Wiater et al., 1971b), both of which
have a chemical structure related to that of an imidazolate anion.
To determine whether the mode of binding of 1,2,4-triazole re-
sembles that of the substrate imidazolate seen in the form
B structure, we co-crystallized wild-type IGPD2 with 1,2,4-tria-
zole and obtained a 1.3 A˚ resolution structure of the complexfor clarity. The atom colors, metal interactions, and electron density are shown
as in (A). See also Figure S2.
(C) 1,2,4-Triazole (orange carbons) binds between the metal ions, each of
which is octahedrally coordinated. The 1.3-A˚ 2mFo-DFc electron density map
(gray mesh) surrounding the triazole is contoured at 1.5 s. The protein back-
bone and side-chain carbon atoms are shown in silver with other atoms shown
in atom colors as in (A). The manganese ions, coordinating waters, and metal
ion interactions are labeled and shown as in (A).
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Figure 3. Comparison of the Mode of Binding of IGP in the Form A and Form B Complexes
(A) An overview of themode of binding of IGP in the form A complex. The protein backbone and side-chain carbon atoms are shown in a different shade of blue for
each chain, and the substrate carbon atoms are shown in green. The non-carbon atoms, water molecules, metal ions, and metal and hydrogen bonding in-
teractions are all drawn, labeled, and colored as in Figure 2. See also Figure S3.
(B) Detail around the metal binding site in the form A complex, including the superimposed position of HOH2 from the holoenzyme complex (yellow sphere with
dots representing the van der Waals radius). The binding of the neutral IGP-imidazole displaces HOH2 from the coordination sphere of Mn2, leaving themetal ion
five-coordinate. Figure drawn as in (A).
(C) A schematic drawing depicting the five ligands that coordinate Mn2 in the form A complex. The manganese ion is represented as a purple sphere.
(D) An overview of themode of binding of IGP in the form B complex. The protein backbone and side-chain carbon atoms are shown in a different shade of orange
for each chain, the substrate carbon atoms are yellow, and the C loop is highlighted in red. The non-carbon atoms, water molecules, metal ions, and metal and
hydrogen bonding interactions are all drawn, labeled, and colored as in Figure 2. See also Figure S4.
(E) Detail around the metal binding site in the form B complex showing that the IGP-imidazolate is bound between the two Mn(II) ions, both of which are
octahedrally coordinated. Figure drawn as in (D).
(F) A schematic drawing depicting the octahedral metal coordination around Mn2 in the form B structure. The manganese ion is represented as a purple sphere.(Table 1). The conformation of the enzyme in this structure was
similar to that of the holoenzyme, including the disordered C
loop, and a number of water molecules were seen to occupy
the available hydrogen bonding positions within the phosphate
binding site. Electron density between the two metal ions clearly
showed that 1,2,4-triazole binds between the metal ions, with
the N1 and N4 nitrogen atoms coordinating Mn1 and Mn2,
respectively, replacing HOH3 and HOH2 from the holoenzyme
structure (Figure 2C). Both of the manganese ions are therefore
octahedrally coordinated and lie in the plane of the triazole ring.
1,2,4-Triazole binds in an equivalent way to that of the imidazo-
late in the form B complex, suggesting that inhibition of IGPD by
1,2,4-triazole is based on it mimicking the mode of binding of the
high-energy imidazolate intermediate.
DISCUSSION
Interconversion between the A and B Forms Reveals
Novel Features of the IGPD Reaction Mechanism
We take the view that the two enzyme-substrate complexes pre-
sented here represent two different snapshots of the early steps1240 Structure 23, 1236–1245, July 7, 2015 ª2015 Elsevier Ltd All rigin the reaction pathway of IGPD. The form A complex demon-
strates how the open form of the enzyme can capture the neutral
imidazole form of IGP. This is consistent with the expectation
that, at biological pH, the neutral form of IGP would predominate
over the imidazolate in solution by 107-fold, given the pKa of
14.5. In contrast, in form B the enzyme is in a closed conforma-
tion due to the ordered C loop. This is associated with the pro-
duction of an imidazolate anion, the charge on which is critical
for the subsequent dehydration step of the reaction, where pi-
electron donation leads to loss of the C3 hydroxyl, facilitated
by the weak electron-withdrawing nature of Mn(II). The form B
complex thus represents a trapped intermediate state of the re-
action. The interconversion of the form A and form B structures
therefore describes progress through the reaction, in a process
that is clearly associated with a number of dramatic torsion angle
changes to the IGP, the switch in coordination chemistry at Mn2,
and the ordering of the C loop. We presume that these structural
changes reflect the molecular processes that dominate the early
steps in catalysis, and to investigate the processes that facilitate
production of the imidazolate we have analyzed the conforma-
tional changes that occur during interconversion between thehts reserved
Table 2. Average Metal-Ligand Distances (A˚)
IGPD2 + Pie
IGPD2+
1,2,4-Triazole
E21Q IGPD2
Form A + IGP
E21Q IGPD2
Form B + IGP
Mn1 coordination number 6 6 6 6
HOH3 or equivalenta 2.30 (2.22–2.47) 2.26 2.35 2.30
HOH4 or equivalentb 2.42 (2.36–2.47) 2.29 2.41 2.33
OE1 Glu173 2.19 (2.15–2.23) 2.17 2.15 2.16
NE2 His47 2.27 (2.22–2.29) 2.29 2.25 2.26
NE2 His169 2.24 (2.20–2.30) 2.31 2.26 2.30
NE2 His74 2.25 (2.22–2.28) 2.30 2.26 2.30
Mean 2.27 2.27 2.28 2.28
Mn2 coordination numberc 6 6 6 5 6
HOH1 2.20 (2.13–2.26) 2.27 2.06 2.19 2.21
HOH2 or equivalentd 2.25 (2.20–2.26) 2.25 2.29 – 2.18
NE2 His170 2.24 (2.22–2.27) 2.27 2.28 2.16 2.29
NE2 His145 2.28 (2.22–2.32) 2.31 2.45 1.99 2.31
NE2 His73 2.24 (2.20–2.26) 2.25 2.19 2.19 2.24
OE1 Glu77 2.32 (2.28–2.35) 2.30 2.33 2.33 2.40
Mean 2.25 2.28 2.26 2.17 2.27
aEquivalents are either the IGP-imidazole, IGP-imidazolate, or 1,2,4-triazole N1 atom.
bEquivalents are either the C2-OH or C3-OH substituents of IGP.
cThe ligand distance around Mn2 for the two diastereoisomers of IGP in the form A structure are shown separately.
dEquivalent is the 1,2,4-triazole N4 atom.
eMean distances across all eight monomers in the asymmetric unit; range of measured distances is shown in parentheses.open and closed states of the enzyme-substrate complex (Fig-
ure 5 andMovie S1). In the following sections, we analyze the im-
plications of this for the mechanism of the enzyme.
Electrostatic and Kinetic Roles for the Manganese Ions
in Catalysis
The structures described here clearly point to two critical elec-
trostatic roles for the manganese ions in facilitating the deproto-
nation of the imidazole during the first step in catalysis. In the
form A structure, where the imidazole-N1 nitrogen atom ligates
Mn1 and the N3 nitrogen is hydrogen bonded to HOH1 (Fig-
ure 3B), the electron-withdrawing effect of Mn1 is likely to reduce
the pKa of the protonated imidazole-N3 nitrogen atom. This sug-
gests that the way that the substrate interacts with Mn1 during
the initial binding phase of the reaction lowers the energy barrier
to deprotonation of N3 and formation of the imidazolate. Analysis
of the form B structure provides evidence for a second electro-
static role for the manganese ions. In this structure, the mode
of binding of the negatively charged imidazolate between the
pair of manganese ions results in the metal ions becoming
shielded from the repulsion that they exert on each other (Fig-
ure 3E). The pair of manganese ions in IGPD therefore acts as
a coulombic trap for the negatively charged imidazolate
intermediate.
The form B structure also demands that as the substrate imid-
azole is converted to an imidazolate, its N3 nitrogen occupies the
position of HOH2 within the coordination sphere of Mn2 in the
holoenzyme. However, restrictions arising from the shape of
the active site require that the direction of approach to Mn2 of
the incoming imidazolate-N3 atom would be the same as that
of an outgoing water molecule, creating a steric problem thatStructure 23, 1the enzyme must resolve. Analysis of the form A structure pro-
vides an elegant explanation as to how the enzyme provides a
sterically unopposed route for the capture of the imidazolate.
When the enzyme binds the substrate, HOH2 is ejected from
the active site and Mn2 is rendered five-coordinate. This leaves
a vacant ligand position at Mn2 for the imidazolate to occupy
once it has been formed, which simultaneously restores the
octahedral coordination of this metal ion. Moreover, the form A
complex shows that the imidazole-N3 atom forms a hydrogen
bond to HOH1 (Figure 5A), which places this water molecule in
an ideal position to act as a base for removal of the proton
from N3. This arrangement shows that, together with the
conserved carboxyls (E77 and D108) that are hydrogen bonded
to HOH1, the active site contains a proton relay system that pro-
vides a path to solvent for the departing proton. Taken together,
these data suggest that the binding mode of the substrate
primes the IGPD active site for catalysis. This is critically depen-
dent on the generation of the five-coordinate manganese ion,
which solves the kinetic problem of providing a catalytically pro-
ductive pathway.
The Five-Coordinate Mn(II) Ion Leads to Weak Substrate
Binding in IGPD
In the reaction, the equilibrium between the imidazole/five-coor-
dinate Mn2 ion and the imidazolate/six-coordinate Mn2 ion is
presumably significantly shifted compared with the deprotona-
tion of imidazole to imidazolate in water. Although it is not
possible to reliably estimate the free energy changes associated
with generating a five-coordinate manganese ion, pentacoordi-
nate-Mn complexes have only been observed in metalloen-
zymes associated with changes in redox state of Mn(II) to Mn(III),236–1245, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1241
Figure 4. A Comparison of the Two Phosphate Binding Sites
Observed in the Form A and Form B Complexes
(A) The interactions between the phosphate group of the IGP (green carbons)
and the enzyme in form A. Hydrogen bonds are shown as orange dashes.
Representation of the metal ion, backbone, and side-chains colors is the same
as in Figures 3A and 3B.
(B) The interactions between the phosphate group of the IGP (yellow carbons)
and the enzyme in form B. Hydrogen bonds are drawn as orange dashes.
HOH5 is labeled and shown as a red sphere. Representation of the metal ion,
backbone, and side-chains colors, including the red C loop, is the same as in
Figures 3D and 3E.
(C) A superposition of the structures shows that the ordering of the C loop (red)
in form B repositions the phosphate group into a site that is 2.2 A˚ away from
that in form A (double-headed arrow). There are also minor differences in the
conformation of the side chains surrounding the two sites.such as oxalate oxidase and superoxide dismutase (Barynin
et al., 2001; Edwards et al., 1998). In the IGPD reaction there is
no change in the redox state of the manganese and, thus, the
switch in coordination from six to five seems likely to incur an en-
ergy penalty. In A. thaliana IGPD2 the Km for IGP (170 mM) is
rather high (Figure S5), despite numerous stabilizing interactions
formed between the substrate and the enzyme in the form A
complex (Figure 3A). This suggests that, unless the following cat-
alytic step is very fast, the weak binding of the substrate could be
explained by the energy penalty incurred by the generation of the
five-coordinate metal center at Mn2.
The C Loop Triggers Conformational Changes that Are
Critical for Diazafulvene Production
Comparison of the form A and form B structures shows that
there is a disorder/order transition of the C loop during the reac-
tion. Since the position of the ordered C loop in form B is incom-
patible with the position of the phosphate group of IGP in form
A, we propose that ordering of the C loop triggers the move-
ment of the phosphate group of the IGP from the form A site
to the form B site during the reaction. This shift in the phosphate1242 Structure 23, 1236–1245, July 7, 2015 ª2015 Elsevier Ltd All rigis accompanied by changes to the IGP torsion angles and an
exchange of the C3-OH of IGP for the C2-OH as a ligand to
Mn1. We have modeled these torsion angle changes to deter-
mine the optimal path of rotation (Movie S1). The only move-
ment that avoids potential steric hindrance between the
C3-OH and other residues in the active site involves the C2-
OH and C3-OH passing each other as they move toward, and
away from, Mn1, respectively. During this rotation the C3-OH
is transiently perpendicular to the imidazolate ring, maximizing
the overlap of its anti-bonding orbital with the pi-electron sys-
tem of the ring. This is the exact requirement for the geometry
of the optimal transition state that leads to the loss of the C3
hydroxyl from the imidazolate intermediate, to form the diazaful-
vene intermediate (Nasipuri, 1991). When the C3-OH is perpen-
dicular to the imidazolate ring it is within 3.3 A˚ of one of the
carboxylate oxygens of E21 (Figure 5B), which is the proposed
acid-base catalyst involved in diazafulvene formation. Further-
more, oscillation of the substrate torsion angles around a form
B-like structure would allow this transition state to be accessed
at a higher frequency, favoring production of the diazafulvene
(Figure 5C).
The Form B Structure Indicates How IGPD Catalyzes
the Conversion of the Diazafulvene to IAP
In the next stage of the reaction, the diazafulvene is converted to
an enolic intermediate by abstraction of theC2 proton, prior to an
enzyme-catalyzed tautomerization that leads to the product, IAP
(Glynn et al., 2005). The similarity of themode of binding of IGP in
the form B structure to a diazafulvene allows us to examine con-
version to the enol intermediate and the final product, IAP. In
form B, the C2-OH of the IGP ligates Mn1 and, thus, the C2-H
is rendered more acidic due to its proximity to the metal ion.
This would favor the loss of the proton from the diazafulvene dur-
ing the reaction, in a process that is likely to be catalyzed by
E173, the carboxyl of which is immediately adjacent to the C2
(3.5 A˚) (Movie S1). This residue is also conveniently placed to
participate in the enzyme-catalyzed tautomerization of the enol
to IAP.
Switching Coordination Chemistry: Understanding the
Role of Specific Metal Ions in Controlling Enzyme
Catalysis
The studies described here provide a molecular explanation of
the unusual dehydration mechanism catalyzed by IGPD. Central
to this is the enzyme-catalyzed formation of a high-energy imida-
zolate intermediate, without which the reaction rate at pH 7
would be limited by the rate of productive substrate binding.
We have demonstrated how changes in manganese coordina-
tion chemistry dominate all aspects of catalysis in IGPD. In the
first part of this process, the enzyme harnesses the substrate
binding energy to create a distorted, ligand-depleted metal cen-
ter, which serves to remove kinetic barriers to the production of
the imidazolate intermediate. Subsequently, a second switch in
coordination chemistry restores the octahedral coordination of
themetal ion, leading to critical torsion angle changes to the sub-
strate that are essential for concomitant production of the diaza-
fulvene. More widely in biology, the loss of a ligand from an octa-
hedrally coordinated metal ion is not without precedence, for
example the changes in coordination state of iron in both solublehts reserved
Figure 5. The Reaction Mechanism of IGPD
(A) Stereo view to show the initial binding mode of
the substrate to IGPD. IGP (green carbons) binds
with a neutral imidazole ring, displacing HOH2 and
leading to five-coordinate geometry around Mn2
(maroon sphere). The protonated imidazole-N3
atom forms a hydrogen bond (orange dashes) to
HOH1 (red sphere), which is also hydrogen bonded
to D108 and E77. The protein backbone and side-
chain carbon atoms are shown in white; all non-
carbon atoms are colored as in Figure 4. E21 is
modeled on the basis of its position in thewild-type
complexes, and other relevant side chains are
shown as sticks, with labels omitted for clarity.
Schematics representing the first two steps in the
proposed reaction mechanism accompany the
stereo views with the five-coordinate manganese
ion, Mn2, colored maroon and enclosed in a
pentagon. Schematic produced with ChemDraw.
See also Movie S1.
(B) Ordering of the C loop (not shown) induces a
conformational change, triggering deprotonation
of the IGP-imidazole to imidazolate (yellow car-
bons) and restoring the octahedral coordination of
Mn2. This is accompanied by the exchange of the
C3-OH for the C2-OH as the ligand to Mn1 and
repositioning of the IGP-phosphate. During sub-
strate rearrangement between the form A and form
B states, the C3-OH is transiently perpendicular
(partially transparent) to the imidazolate, which is
required for C3-OH elimination. A double-headed
arrow represents oscillation around the interme-
diate. E21 is within close proximity (3.3 A˚) to the
C3-OH (pink dashes). Figure is drawn as in (A).
(C) The modeled position of the diazafulvene in-
termediate (lime green) in which the C3-OH has
been eliminated. Figure is drawn as in (A).methane monooxygenase (Rosenzweig et al., 1993) and hemo-
globin (Perutz, 1970). Although five-coordinate Mn(II) centers
and changes in coordination states have also been observed in
the structures of both manganese superoxide dismutase and
oxalate decarboxylase (Tabares et al., 2005, 2009) their roles,
unlike IGPD, are associated with changes in metal redox state
during the reaction. To our knowledge, the work on IGPD pre-
sented here is the first description of how an enzyme can exploit
the unique ability of transition metals to switch coordination
states at specific steps in catalysis. In IGPD this facilitates a high-
ly choreographed and dynamic process that controls the reac-
tion mechanism at every stage. This role of metal ions may
well be a more important driver to catalysis than is currently
recognized.EXPERIMENTAL PROCEDURES
Cloning and Mutagenesis
Two DN constructs of the gene encoding for IGPD2 from A. thaliana were de-
signed to remove an N-terminal signal peptide and cloned into pET24a vectors
(Novagen). Construct A (residues 54–272), was provided as a synthetic gene
(GeneArt) and construct B (residues 69–272), which was further truncated at
the N terminus, was cloned from the original construct. The E21Q mutant
was made by introducing a point mutation to construct B by QuickChange
site-directed mutagenesis (Stratagene), subsequently verified by sequencing
(GeneServices). The IGPD2 complex with phosphate was determined fromStructure 23, 1crystals grown with construct A, while the 1,2,4-triazole complex was deter-
mined using construct B. The gene encoding for IGPD from Pfwas PCR ampli-
fied with a mutation to the start codon, which replaced a GTG with an ATG,
before ligation into pETBlue (Novagen). A DC construct of the Pf enzyme
was also cloned from the full-length gene, introducing a premature stop
codon, which removed the C-terminal loop region of the protein (residues
170–176). The DC construct was subsequently cloned into a pET24a vector
for protein expression.
Expression and Purification
Plasmids encoding for IGPD2 were transformed into Escherichia coli
BL21(DE3) cells (Novagen) and protein expression was induced for 5 hr with
1 mM isopropyl-b-D-thiogalactopyranoside at 37C in Luria broth, supple-
mented with 5 mM MnCl2. Plasmids encoding for the Pf IGPD were trans-
formed into Tuner DE3 cells (Novagen) and expressed using the samemethod,
but for 3 hr and supplemented with 4 mM MnCl2. Cells were harvested and
lysed by sonication. For IGPD2, insoluble material was removed by centrifuga-
tion and the cell-free extract was purified in a process involving anion-ex-
change, hydrophobic, and size-exclusion chromatography, combined with
ammonium sulfate precipitation. For Pf IGPD, cell-free extract was heated to
70C for 20 min, before purification using anion-exchange and size-exclusion
chromatography. All proteins were analyzed after each stage by SDS-PAGE.
Crystallization and Data Collection
Prior to crystallization, substrate (Toronto Research) or inhibitor (Sigma) were
added to the protein (10 mg ml1 in 50 mM Bis-Tris propane buffer [pH 8.0],
50mMNaCl, 10mM b-mercaptoethanol, and 0.4mMMnCl2) at a final concen-
tration of 5 mM. Initial crystallization conditions were determined by auto-
mated screening (Nextal) using a Matrix Hydra II crystallization robot. Crystals236–1245, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1243
were optimized by hanging-drop vapor diffusion using a 5:1 ratio of protein to
precipitant, which yielded cubic crystals after 5–10 days when equilibrated
against a 1-ml reservoir of precipitant at a temperature of 17C. Crystals
were cryoprotected in their crystallization solution containing 25%–30%
ethylene glycol, prior to flash-cooling in liquid nitrogen. All data sets were
collected on the MX beamlines at the Diamond Light Source. The two mutant
complexes with IGP and the 1,2,4-triazole complex belonged to the space
group P432 with cell dimensions of az 113 A˚. The structure with phosphate
was determined to be in the space group I23 with cell dimensions of a = 225 A˚.
The data collection statistics are summarized in Table 1.
Structure Determination and Refinement
Data were processed using Xia2 (Winter, 2010) or by integration using iMosflm
(Leslie and Powell, 2007). All additional data processing was carried out with
CCP4i (Winn et al., 2011). The IGPD2 complexwith phosphatewas determined
bymolecular replacement using PHASER (McCoy et al., 2007) with amonomer
of A. thaliana IGPD1 (PDB: 2F1D) (Glynn et al., 2005) as a search model
(sequence identity 96%). The 1,2,4-triazole complex was determined by
the same method, using the refined protein coordinates from the phosphate
complex as a search model. All other structures were directly refined using
the protein atoms from the phosphate complex, but omitting ligands, metal
ions, and solvent. Model building and refinement was carried out in Coot (Ems-
ley and Cowtan, 2004) and Refmac5 (Murshudov et al., 1997), with ligand li-
braries generated by JLigand (Lebedev et al., 2012). Refinement statistics
are summarized in Table 1. For all structures, no electron density was visible
for the residues before S75, which was renumbered S9 for consistency with
the structure of IGPD1 fromA. thaliana (PDB: 2F1D) (Glynn et al., 2005). Models
were validated usingMolProbity (Chen et al., 2010) and figures were generated
using Pymol (Shrodinger, LLC).
Determining the Km of IGP Binding to IGPD2
The Km was determined using a modified coupled assay (Hawkes et al., 1995).
Assay buffer was combined with bovine glutamate dehydrogenase (Sigma)
and a large excess of imidazoleacetol-phosphate transaminase (S. Singh,
Syngenta). Reduced nicotinamide adenine dinucleotide (Sigma) and IGPD2
were added to a final concentration of 6 mM and 45 nM, respectively, before
incubation at 30C in a temperature-controlled spectrophotometer. When
the signal at 340 nm had stabilized, IGP was added at various concentrations
to start the reaction. Initial rates from the linear part of the curve were recorded,
and Km and Kcat were determined by non-linear least-squares fitting in Graph-
Pad Prism.
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